Triple
T4221592
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cambridge life sciences ecosystem |
E94351
|
entity |
| Predicate | hasKeyCompany |
P51457
|
FINISHED |
| Object |
Kymab
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
|
E422485
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Kymab | Statement: [Cambridge life sciences ecosystem, hasKeyCompany, Kymab]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Kymab Context triple: [Cambridge life sciences ecosystem, hasKeyCompany, Kymab]
-
A.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
B.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
C.
Immunix
Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
-
D.
Behring
Behring is a German surname most notably associated with Emil Adolf von Behring, the pioneering physiologist and first Nobel laureate in Physiology or Medicine for his work on serum therapy.
-
E.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Kymab Triple: [Cambridge life sciences ecosystem, hasKeyCompany, Kymab]
Generated description
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Kymab Target entity description: Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
-
A.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
B.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
C.
Immunix
Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
-
D.
Behring
Behring is a German surname most notably associated with Emil Adolf von Behring, the pioneering physiologist and first Nobel laureate in Physiology or Medicine for his work on serum therapy.
-
E.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b3451997e08190851db4a9a588837d |
completed | March 12, 2026, 10:58 p.m. |
| NER | Named-entity recognition | batch_69b34f7d20b48190a404638c68c31026 |
completed | March 12, 2026, 11:42 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b59642720c81908e68a56b3d30eef9 |
completed | March 14, 2026, 5:09 p.m. |
| NEDg | Description generation | batch_69b596cb73ac81909f83daca406ad8c4 |
completed | March 14, 2026, 5:11 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b59a9c386081909c21ad554d403bfc |
completed | March 14, 2026, 5:27 p.m. |
Created at: March 12, 2026, 11:04 p.m.